RASO, Simona
 Distribuzione geografica
Continente #
NA - Nord America 3.359
EU - Europa 1.779
AS - Asia 927
SA - Sud America 132
OC - Oceania 127
AF - Africa 121
Continente sconosciuto - Info sul continente non disponibili 6
Totale 6.451
Nazione #
US - Stati Uniti d'America 3.228
IT - Italia 497
DE - Germania 460
CN - Cina 232
GB - Regno Unito 189
IN - India 165
FR - Francia 161
AU - Australia 110
CA - Canada 89
ID - Indonesia 64
JP - Giappone 60
NL - Olanda 60
HK - Hong Kong 50
IR - Iran 50
BR - Brasile 49
ES - Italia 49
RU - Federazione Russa 46
IE - Irlanda 44
CH - Svizzera 40
EG - Egitto 40
MX - Messico 38
MY - Malesia 38
TH - Thailandia 33
KR - Corea 30
TW - Taiwan 29
CZ - Repubblica Ceca 28
TR - Turchia 28
RO - Romania 27
SG - Singapore 25
PE - Perù 24
SE - Svezia 24
PL - Polonia 23
ZA - Sudafrica 21
CL - Cile 20
VN - Vietnam 19
IQ - Iraq 18
NG - Nigeria 18
AT - Austria 17
NZ - Nuova Zelanda 17
EC - Ecuador 16
PT - Portogallo 16
IL - Israele 15
PH - Filippine 14
CO - Colombia 13
PK - Pakistan 11
SA - Arabia Saudita 11
SK - Slovacchia (Repubblica Slovacca) 11
UA - Ucraina 11
LT - Lituania 10
GR - Grecia 9
FI - Finlandia 8
AR - Argentina 7
KE - Kenya 7
RS - Serbia 7
AE - Emirati Arabi Uniti 6
BE - Belgio 6
DZ - Algeria 6
HR - Croazia 6
MK - Macedonia 6
QA - Qatar 6
DK - Danimarca 5
EU - Europa 5
JO - Giordania 5
TN - Tunisia 5
BD - Bangladesh 4
BJ - Benin 4
BW - Botswana 4
HU - Ungheria 4
MA - Marocco 4
NO - Norvegia 4
EE - Estonia 3
ET - Etiopia 3
LK - Sri Lanka 3
MT - Malta 3
SI - Slovenia 3
SN - Senegal 3
UG - Uganda 3
LB - Libano 2
MO - Macao, regione amministrativa speciale della Cina 2
PS - Palestinian Territory 2
UY - Uruguay 2
AP - ???statistics.table.value.countryCode.AP??? 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
DO - Repubblica Dominicana 1
HN - Honduras 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MD - Moldavia 1
NP - Nepal 1
PA - Panama 1
SZ - Regno dello Swaziland 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZW - Zimbabwe 1
Totale 6.451
Città #
Fairfield 468
Houston 307
Ashburn 296
Woodbridge 254
Seattle 191
Wilmington 174
Cambridge 157
Santa Cruz 152
Buffalo 113
Ann Arbor 109
Des Moines 98
Palermo 76
Beijing 54
Shanghai 46
Dublin 37
Verona 36
Milan 32
Rome 30
Nanjing 29
Duncan 28
Nürnberg 28
San Diego 28
Boardman 26
Jakarta 26
Mumbai 25
Kuala Lumpur 23
Madrid 23
Bengaluru 21
Ottawa 20
Mountain View 19
Los Angeles 18
Sheffield 18
Taipei 18
London 16
Muizenberg 16
New York 16
São Paulo 16
Birmingham 15
Central 15
Chennai 15
Chicago 15
Chiclayo 15
San Jose 15
Sydney 15
Tokyo 15
Zurich 15
Bangkok 14
Brisbane 13
Clearwater 13
Hangzhou 13
Santiago 13
Bandung 12
Basel 12
Lyon 12
Paris 12
Seoul 12
Jerusalem 11
Las Vegas 11
Maastricht 11
Mexico City 11
Vienna 11
Amsterdam 10
Cologne 10
Dallas 10
Guangzhou 10
Quito 10
Rockville 10
Toronto 10
Wuhan 10
Cairo 9
Calgary 9
Redmond 9
University Park 9
Atlanta 8
Bedford 8
Bologna 8
Chengdu 8
Lima 8
Milpitas 8
Riva 8
Chapel Hill 7
Columbus 7
Florence 7
Phoenix 7
Piemonte 7
Trieste 7
Auckland 6
Belgrade 6
Caserta 6
Catania 6
Chiang Mai 6
Doha 6
Easton 6
Jacksonville 6
Mashhad 6
Melbourne 6
Monterrey 6
Osaka 6
Palo Alto 6
Provo 6
Totale 3.658
Nome #
Lonoctocog alfa (rVIII-SingleChain) for the treatment of haemophilia A, file e3ad891e-f13e-da0e-e053-3705fe0a2b96 1.105
Recombinant factor VIII: Past, present and future of treatment of hemophilia A, file e3ad891e-f140-da0e-e053-3705fe0a2b96 1.044
Drug-Related Cardiotoxicity for the Treatment of Haematological Malignancies in Elderly., file e3ad8915-e709-da0e-e053-3705fe0a2b96 746
Safety of plasma-derived protein C for treating disseminated intravascular coagulation in adult patients with active cancer., file e3ad8916-746e-da0e-e053-3705fe0a2b96 610
Absolute Lymphocyte Count Is Unrelated to Overall Survival in Newly Diagnosed Elderly Patients with Multiple Myeloma Treated with Immunomodulatory Drugs., file e3ad8916-c6ba-da0e-e053-3705fe0a2b96 476
Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: the extended DACUS study., file e3ad8916-80e4-da0e-e053-3705fe0a2b96 391
Clinical phenotype and response to different lines of therapy in elderly with immune thrombocytopenia: A retrospective study, file e3ad8922-bb61-da0e-e053-3705fe0a2b96 255
Peripheral circulating cells with paroxysmal nocturnal haemoglobinuria phenotype after a first episode of cerebral sinus vein thrombosis: Results from a multicentre cross-sectional study, file e3ad8920-5bea-da0e-e053-3705fe0a2b96 231
Cancer patients requiring interruption of long-term warfarin because of surgery or chemotherapy induced thrombocytopenia: the use of fixed sub-therapeutic doses of low-molecular weight heparin., file e3ad8916-77c5-da0e-e053-3705fe0a2b96 175
Immunosenescence and lymphomagenesis, file e3ad891e-e93f-da0e-e053-3705fe0a2b96 164
Buffy coat-derived platelets cryopreserved using a new method: Results from a pivotal clinical trial on thrombocytopenic patients with acute leukaemia, file e3ad8920-aff4-da0e-e053-3705fe0a2b96 164
Splenomegaly impacts prognosis in essential thrombocythemia and polycythemia vera: A single center study, file e3ad8921-882c-da0e-e053-3705fe0a2b96 162
Combined Point of Care Tools Are Able to Improve Treatment Adherence and Health-Related Quality of Life in Patients with Severe Hemophilia: An Observational Prospective Study, file e3ad8920-8dba-da0e-e053-3705fe0a2b96 149
CARDIOVASCULAR RISK IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA: THROMBOTIC RISK AND SURVIVAL, file e3ad8921-f5e8-da0e-e053-3705fe0a2b96 144
Late onset of unilateral optic disk edema secondary to treatment with imatinib mesylate, file e3ad891b-1fd0-da0e-e053-3705fe0a2b96 127
Acquired Hemophilia A Associated with Venous Thrombosis and Very High Inhibitor Titer: A Challenging Scenario, file e3ad8921-d29e-da0e-e053-3705fe0a2b96 115
Emotions and Opinions of Adult Patients with Haemophilia During the COVID-19 (Coronavirus Disease 2019) Pandemic Caused by SARS-CoV-2: A Monocentric Survey, file e3ad8922-972f-da0e-e053-3705fe0a2b96 108
The Essential Thrombocythemia, Thrombotic Risk Stratification, and Cardiovascular Risk Factors, file e3ad8921-cca5-da0e-e053-3705fe0a2b96 104
Quality of Life in Patients With Cancer Under Prolonged Anticoagulation for High-Risk Deep Vein Thrombosis: a Long-Term Follow-Up, file e3ad8921-666a-da0e-e053-3705fe0a2b96 103
Diagnosis and management of coagulation derangements in patients with acute leukemia: is there a potential role for thromboelastography?, file e3ad8926-d0e9-da0e-e053-3705fe0a2b96 95
Antimicorbial prophylaxis in patients with immune thrombocytopenia treated with rituximab:a retrospective analysis, file e3ad891e-6427-da0e-e053-3705fe0a2b96 65
"Long term anticoagulant treatment management in patients with portal vein thrombosis at high bleeding risk", file e3ad891b-1ac6-da0e-e053-3705fe0a2b96 42
A Patient with Sickle Cell Disease and Recurrent Venous Thromboembolism after Renal Transplantation, file 0bbed207-c95c-4ec2-995c-824a42f3e885 31
A Multicenter Real-Life Study On Anticoagulant Treatment With Direct Oral Anticoagulants In Patients With Ph Negative Myeloproliferative Neoplasms, file 1b759ca9-0fb0-4cb5-b0e1-bc45d4fccbb8 21
The First Case of Haemophagocytic Lymphohistiocytosis Triggered by the Booster Dose of Anti-SARS-CoV-2 Vaccine in a Patient with β-Thalassemia, file e3ad8928-d520-da0e-e053-3705fe0a2b96 13
Personalized prophylaxis with simoctocog-alfa(human-cl rhFVIII):A real-life experience on children and moderate haemophilia A patients, file e3ad891e-70f0-da0e-e053-3705fe0a2b96 8
Coexistence of Von Willebrand disease and gastrointestinal stromal tumor (G.I.S.T): Case report of a rare and challenge association, file e3ad8922-8a8a-da0e-e053-3705fe0a2b96 5
Cardiovascular risk in polycythemia vera: Thrombotic risk and survival: Can cytoreductive therapy be useful in patients with low-risk polycythemia vera with cardiovascular risk factors?, file e3ad8922-a36c-da0e-e053-3705fe0a2b96 5
Can we compare haemophilia carriers with clotting factor deficiency to male patients with mild haemophilia?, file e3ad8920-705c-da0e-e053-3705fe0a2b96 4
Plasma viscosity pattern and erythrocyte aggregation in two patients with congenital afibrinogenemia, file e3ad8921-695d-da0e-e053-3705fe0a2b96 4
Comparison between thrombotic risk scores in Essential Thrombocythemia and survival implications, file e3ad8920-ab2b-da0e-e053-3705fe0a2b96 3
ABSOLUTE LYMPHOCYTE COUNT AS PREDICTOR FOR SURVIVAL IN NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMA, file e3ad8916-68f9-da0e-e053-3705fe0a2b96 2
Real-world use of ticagrelor and prasugrel in patients with NSTEMI undergoing percutaneous coronary intervention, file e3ad891b-178d-da0e-e053-3705fe0a2b96 2
Buffy coat-derived platelets cryopreserved using a new method: Results from in vitro studies, file e3ad891c-e309-da0e-e053-3705fe0a2b96 2
The Essential Thrombocythemia, Thrombotic Risk Stratification, and Cardiovascular Risk Factors, file e3ad8921-fc9c-da0e-e053-3705fe0a2b96 2
Pain assessment and management in Italian Haemophilia Centres, file e3ad8923-7069-da0e-e053-3705fe0a2b96 2
Global hemostasis assays in acute myeloid leukemia: results of an observational prospective study, file b54e9553-730d-424a-9d01-d3f9375c2ba5 1
PREDICTORS OF RESIDUAL VEIN THROMBOSIS AFTER CANCER-RELATED DEEP VEIN THROMBOSIS OF THE LOWER LIMBS, file e3ad8916-6515-da0e-e053-3705fe0a2b96 1
ABSOLUTE LYMPHOCYTE COUNT IS NOT A PREDICTOR FOR SURVIVAL IN NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMA, file e3ad8916-698c-da0e-e053-3705fe0a2b96 1
ABSOLUTE LYMPHOCYTE COUNT IS NOT A PREDICTOR FOR SURVIVAL IN NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMA. FINAL RESULTS OF A MULTICENTER STUDY, file e3ad8916-7036-da0e-e053-3705fe0a2b96 1
Acquired Hemophilia A Associated with Venous Thrombosis and Very High Inhibitor Titer: A Challenging Scenario, file e3ad8921-dc50-da0e-e053-3705fe0a2b96 1
Antimicrobial prophylaxis in patients with immune thrombocytopenia treated with rituximab: a retrospective multicenter analysis, file e3ad8924-9f16-da0e-e053-3705fe0a2b96 1
Totale 6.685
Categoria #
all - tutte 12.527
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.527


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019131 0 0 0 0 0 0 0 0 0 0 88 43
2019/2020770 43 38 40 109 60 75 56 56 73 103 64 53
2020/20211.549 75 100 260 227 165 118 93 114 90 98 124 85
2021/20221.394 81 139 106 162 142 70 88 94 92 84 223 113
2022/20231.115 57 82 165 175 79 67 134 65 64 73 109 45
2023/2024852 63 56 74 120 110 71 100 144 36 74 4 0
Totale 6.685